Patterns of hepatic impairment in phase I clinical trials. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
Bioavailability of the hedgehog pathway inhibitor GDC-0449 in a phase I pharmacokinetic (PK) study in healthy female subjects. Background: Serdemetan is a compound that can cause replicative stress ...
Developed by the Institute for Clinical Pharmacodynamics, the PK-PD Compass app provides pharmacodynamics (PD) and pharmacokinetics (PK) calculations as they pertain to antibiotics. The goal of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results